Literature DB >> 24910946

Medium-term variability of the human serum metabolome in the Atherosclerosis Risk in Communities (ARIC) study.

Yan Zheng1, Bing Yu, Danny Alexander, David J Couper, Eric Boerwinkle.   

Abstract

Metabolomics is a systems biology tool providing small molecule signatures of disease etiology. In order to estimate the biologic variability of the human serum metabolome, this study calculated intraclass correlation coefficients (ICCs) for 178 stably-detected metabolites measured by untargeted chromatography/mass spectrometry. We studied a subsample of 60 participants (57% males, 70% Caucasians, aged 73.77±5.3 years) in the Atherosclerosis Risk in Communities (ARIC) Study who provided two fasting serum samples 4-6 weeks apart. The median ICC across all metabolites was 0.60, and 82% of metabolites had at least fair variability (i.e., ICC>= 0.40). There was variation in the medium-term variability among metabolites, with those in the pathways of amino acid and lipid metabolism showing relatively high ICCs, and those in the carbohydrate pathway showing relatively low ICCs. The results of this study provide a valuable resource for future study design and outcome interpretation of mass spectrometry-based metabolomic studies in epidemiology.

Entities:  

Mesh:

Year:  2014        PMID: 24910946      PMCID: PMC4048570          DOI: 10.1089/omi.2014.0019

Source DB:  PubMed          Journal:  OMICS        ISSN: 1536-2310


  33 in total

1.  Short-term intraindividual variability in lipoprotein measurements: the Atherosclerosis Risk in Communities (ARIC) Study.

Authors:  L E Chambless; R P McMahon; S A Brown; W Patsch; G Heiss; Y L Shen
Journal:  Am J Epidemiol       Date:  1992-11-01       Impact factor: 4.897

Review 2.  Quantifying test-retest reliability using the intraclass correlation coefficient and the SEM.

Authors:  Joseph P Weir
Journal:  J Strength Cond Res       Date:  2005-02       Impact factor: 3.775

3.  Effects of diabetes mellitus on cholesterol metabolism in man.

Authors:  L J Bennion; S M Grundy
Journal:  N Engl J Med       Date:  1977-06-16       Impact factor: 91.245

4.  Metabolomics identifies perturbations in human disorders of propionate metabolism.

Authors:  William R Wikoff; Jon A Gangoiti; Bruce A Barshop; Gary Siuzdak
Journal:  Clin Chem       Date:  2007-10-19       Impact factor: 8.327

Review 5.  Application of metabolomics to cardiovascular biomarker and pathway discovery.

Authors:  Gregory D Lewis; Aarti Asnani; Robert E Gerszten
Journal:  J Am Coll Cardiol       Date:  2008-07-08       Impact factor: 24.094

6.  Reproducibility of metabolomic profiles among men and women in 2 large cohort studies.

Authors:  Mary K Townsend; Clary B Clish; Peter Kraft; Chen Wu; Amanda L Souza; Amy A Deik; Shelley S Tworoger; Brian M Wolpin
Journal:  Clin Chem       Date:  2013-07-29       Impact factor: 8.327

7.  Short- and long-term repeatability of fatty acid composition of human plasma phospholipids and cholesterol esters. The Atherosclerosis Risk in Communities (ARIC) Study Investigators.

Authors:  J Ma; A R Folsom; J H Eckfeldt; L Lewis; L E Chambless
Journal:  Am J Clin Nutr       Date:  1995-09       Impact factor: 7.045

8.  The Atherosclerosis Risk in Communities (ARIC) Study: design and objectives. The ARIC investigators.

Authors: 
Journal:  Am J Epidemiol       Date:  1989-04       Impact factor: 4.897

9.  Metabolism of cholesterol and plasma triglycerides in nonketotic diabetes mellitus.

Authors:  J J Abrams; H Ginsberg; S M Grundy
Journal:  Diabetes       Date:  1982-10       Impact factor: 9.461

10.  Biomarkers for type 2 diabetes and impaired fasting glucose using a nontargeted metabolomics approach.

Authors:  Cristina Menni; Eric Fauman; Idil Erte; John R B Perry; Gabi Kastenmüller; So-Youn Shin; Ann-Kristin Petersen; Craig Hyde; Maria Psatha; Kirsten J Ward; Wei Yuan; Mike Milburn; Colin N A Palmer; Timothy M Frayling; Jeff Trimmer; Jordana T Bell; Christian Gieger; Rob P Mohney; Mary Julia Brosnan; Karsten Suhre; Nicole Soranzo; Tim D Spector
Journal:  Diabetes       Date:  2013-07-24       Impact factor: 9.461

View more
  7 in total

1.  Metabolomics Research in Chronic Kidney Disease.

Authors:  Morgan E Grams; Tariq Shafi; Eugene P Rhee
Journal:  J Am Soc Nephrol       Date:  2018-05-03       Impact factor: 10.121

2.  Identification of Rare Variants in Metabolites of the Carnitine Pathway by Whole Genome Sequencing Analysis.

Authors:  Akram Yazdani; Azam Yazdani; Xiaoming Liu; Eric Boerwinkle
Journal:  Genet Epidemiol       Date:  2016-06-03       Impact factor: 2.135

3.  Repurposing L-Menthol for Systems Medicine and Cancer Therapeutics? L-Menthol Induces Apoptosis through Caspase 10 and by Suppressing HSP90.

Authors:  Uzma Faridi; Sunita S Dhawan; Shaifali Pal; Sanchita Gupta; Ashutosh K Shukla; Mahendra P Darokar; Ashok Sharma; Ajit K Shasany
Journal:  OMICS       Date:  2016-01

4.  Metabolomics and cognition in African American adults in midlife: the atherosclerosis risk in communities study.

Authors:  J Bressler; B Yu; T H Mosley; D S Knopman; R F Gottesman; A Alonso; A R Sharrett; L M Wruck; E Boerwinkle
Journal:  Transl Psychiatry       Date:  2017-07-18       Impact factor: 6.222

5.  Metabolomics and Incidence of Atrial Fibrillation in African Americans: The Atherosclerosis Risk in Communities (ARIC) Study.

Authors:  Alvaro Alonso; Bing Yu; Waqas T Qureshi; Morgan E Grams; Elizabeth Selvin; Elsayed Z Soliman; Laura R Loehr; Lin Y Chen; Sunil K Agarwal; Danny Alexander; Eric Boerwinkle
Journal:  PLoS One       Date:  2015-11-06       Impact factor: 3.240

6.  Short-term variability of the human serum metabolome depending on nutritional and metabolic health status.

Authors:  Inoncent Agueusop; Petra B Musholt; Beate Klaus; Kendra Hightower; Aimo Kannt
Journal:  Sci Rep       Date:  2020-10-01       Impact factor: 4.379

Review 7.  Potential for Novel Biomarkers in Diabetes-Associated Chronic Kidney Disease: Epigenome, Metabolome, and Gut Microbiome.

Authors:  Ashani Lecamwasam; Elif I Ekinci; Richard Saffery; Karen M Dwyer
Journal:  Biomedicines       Date:  2020-09-10
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.